Bill > HR2340

This bill aims to streamline the process for re-exporting controlled substances among countries within the European Economic Area (EEA), which is a bloc of European Union member states plus Iceland, Liechtenstein, and Norway. Specifically, it amends the Controlled Substances Import and Export Act to allow controlled substances that have been exported from the United States to be re-exported between EEA member countries without facing the same regulatory hurdles as other international re-exports. The bill also explicitly prohibits the Attorney General, who oversees the Drug Enforcement Administration (DEA) and enforces the Controlled Substances Act, from creating or enforcing any rules or policies that would hinder this re-exportation within the EEA, such as imposing strict time limits for re-exports or requiring specific information about the recipient country and product before the initial export from the United States.